Study Shows Vitamin K2 Plays Significant Role in Cardiovascular Health
2007-04-02 - VitaK, Maastricht University
Advertisement
Research Published in Blood Journal Leads to New Human Test for Cardiovascular
Disease Risk to Be Presented at American Heart Association Conference ATVB
Conference
April 19-21 2007
WASHINGTON -- April 2, 2007 -- A new study published in the April 1, 2007
(volume 109, number 7) issue of Blood, the official journal of the American
Society of Hematology, suggests that vitamin K2 provides significant benefits
for promoting cardiovascular health. The study shows for the first time that a
high intake of vitamin K significantly reverses arterial calcification induced
with anti-coagulant medication use.
The animal study, conducted by the Cardiovascular Research Institute (CARIM) and
VitaK, Maastricht University, The Netherlands, found that high dose vitamin K
not only blocked new arterial calcium buildup, but also reduced existing levels
by over 37 percent, within only 6 weeks. The most potent inhibitor of vascular
calcification known is matrix GLA protein (MGP), a vitamin K-dependent protein –
meaning vitamin K is required to activate this important protein. In humans,
oral anticoagulants that interfere with vitamin K (warfarins) block MGP function
and induce calcification. Also, inactive MGP levels in blood are an indicator
of cardiovascular disease, and a new test has been developed to measure these
levels. This new test will be presented at the American Heart Association’s
2007 Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology to
be held April 19-21 at the Palmer House Hilton, Chicago, Illinois.
Calcium buildup in arteries is an early warning sign of increased risk on
coronary heart disease in humans. People with higher arterial calcium levels are
more likely to develop arteriolosclerosis, stroke and other heart ailments later
in life than those with normal levels. Researchers also note as evidence the
increased risk of calcium in blood vessels (arterial calcification) associated
with cardiovascular disease in people with vitamin K-poor diets.
“The medical community now recognizes that vitamin K-dependent MGP plays an
essential role in promoting cardiovascular health,” said lead researcher Leon
Schurgers. “Our study shows that in an animal model vitamin K can actually
regress preformed calcifications. The health implications for humans are
significant, and we have previously published research showing that the highest
vitamin K2 intake from dietary sources has been linked to significant reductions
in vascular calcification compared to those with the lowest K2 intake.”
In a recent 10-year study of 4,800 elderly people published in the Journal of
Nutrition, high vitamin K2 intake was linked to lower coronary heart disease,
less aortic calcification and lower all cause mortality. “Research is showing
much promise associated with vitamin K intake and heart health, and people
should be encouraged to discuss vitamin K use with their physician,” added Dr.
Schurgers.
# # #
http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=18146&zoneid=28
--
Pramesh Rutajit - [email hidden] - Remove tongue to reply.